  Abbreviations, acronyms & symbols   
  ----------------------------------- ------------------------------------
  AA                                  = Ascending aorta
  AV                                  = Aortic valve
  AVA                                 = Aortic valve annulus
  AVNeo                               = Aortic valve neocuspidization
  DTG                                 = Dacron tube graft
  TEE                                 = Transesophageal echocardiography

INTRODUCTION
============

Bentall-DeBono operation for aortic valve (AV) and ascending aorta (AA) replacement with a valve-containing conduit, first performed in 1966, occupies a unique position in the course of development of operations on the aorta. Currently, it is widely used in cardiac surgery and it is considered as a "gold standard" for pathologies affecting AA and AV^\[[@r1],[@r2]\]^. The advantages of this approach are a proven methodology and high-quality long-term results. The well-known problems associated with this surgical procedure include, among others, complications due to the need to receive anticoagulants when patients choose mechanical prostheses^\[[@r3],[@r4]\]^. Moreover, the use of artificial prostheses has always been associated with a residual pressure gradient, whose severity strongly depends on its type and size and is explained by the presence of a frame and a cuff for fixation, reducing the effective orifice area. Additionally, there is the risk of postoperative infective endocarditis. Bioprostheses, especially in young patients, are prone to structural valve degeneration^\[[@r5]\]^. The exact mechanism through which the fibrosis and/or calcification develops remains undisclosed, being possible the existence of an underlying role of an immune response against the bioprosthesis^\[[@r6],[@r7]\]^.

Ozaki et al.^\[[@r8]\]^ developed a technique for AV cusps replacement, which are cut out according to the original template and made of the patient's pericardium treated with glutaraldehyde. It is fully logical that, with an aortic aneurysm and degeneratively altered AV cusps, the most promising and most physiologically and surgically convenient treatment option would be a combination of Bentall-DeBono operation with Dacron prostheses and aortic valve neocuspidization (AVNeo) with autologous pericardium (Ozaki procedure).

The objective of this paper is to describe the technique with the Russian conduit for execution of the Bentall-Ozaki procedure, so that other surgeons could become familiarized with this new approach in the treatment of patients with AA disease (aneurysm or dissection) associated with AV disease.

TECHNIQUE NUMBER 1
==================

Step 1
------

Access to the heart through median sternotomy ([Figure 1A](#f1){ref-type="fig"}) and autologous pericardium harvesting ([Figure 1B](#f1){ref-type="fig"}) with further processing with 0.6% glutaraldehyde for 8 minutes, then treatment twice for 8 minutes with saline solution. Meanwhile, a transesophageal echocardiography (TEE) is performed in order to measure the aortic valve annulus (AVA).

Fig. 1Step 1.

Step 2
------

The size of the Dacron tube graft (DTG) must be calculated ([Figure 2A](#f2){ref-type="fig"}). If AVA is not enlarged, then the size of the DTG equals AVA plus 5 mm. If AVA is enlarged, then, 30 or 32 mm. Next, the DTG is everted ([Figures 2B](#f2){ref-type="fig"} and [2C](#f2){ref-type="fig"}).

Fig. 2Step 2.

Step 3
------

Determine the size of the cusps by the following formula:

a). If the size of DTG has an even value, then the size of the neocusps equals DTG's size minus 1;b). If the size of DTG has an odd value, then the size of the neocusps equals DTG's size.

For example, with a DTG of size number 28, we apply the formula '28 minus 1 equals 27'. The neocusps' size corresponds to the number 27 on Ozaki's template.

Step 4
------

We cut out three identical cusps from the treated autologous pericardium ([Figures 3A](#f3){ref-type="fig"}, [3B](#f3){ref-type="fig"}, [3C](#f3){ref-type="fig"}, and [3D](#f3){ref-type="fig"})

Fig. 3Step 4.

Step 5
------

A 5-mm straight line is drawn from the lower edge of the DTG (5 mm will be needed to fix the conduit to AVA). Further, we fix the cusps to the DTG with a continuous suture line with prolene ([Figures 4A](#f4){ref-type="fig"}, [4B](#f4){ref-type="fig"}, and [4C](#f4){ref-type="fig"}).

Fig. 4Step 5.

Step 6
------

After fixing the cusps, DTG is everted back to its original side ([Figures 5A](#f5){ref-type="fig"}, [5B](#f5){ref-type="fig"}, [5C](#f5){ref-type="fig"}, and [5D](#f5){ref-type="fig"})

Fig. 5Step 6.

Step 7
------

Cardiopulmonary bypass begins, cardioplegic solution is infused, and native AV cusps are excised. The next step is the implantation of the resulting conduit with fixation of the proximal end to AVA with horizontal mattress stitches. Reimplantation of the coronary ostia is performed according to the standard technique. The procedure ends with a distal anastomosis of DTG with AA ([Figures 6A](#f6){ref-type="fig"} and [6B](#f6){ref-type="fig"}).

Fig. 6Step 7.

TECHNIQUE NUMBER 2
==================

This technique offers a more elaborate option to calculate the size of the DTG and the size of the neocusps (according to [Figures 7](#f7){ref-type="fig"} and [8](#f8){ref-type="fig"}). The diameter of DTG is also based on the previously measured AVA diameter, to which 5 mm is added.

Fig. 7Formulas to calculate the size of the Dacron tube graft (DTG) and of the neocusps.

Fig. 8Formulas to calculate the size of the Dacron tube graft (DTG) and of the neocusps.

Instead of everting DTG, this is cut along longitudinally, which results in a rectangular section ([Figures 7A](#f7){ref-type="fig"} and [7B](#f7){ref-type="fig"}) with a width (w) equal to the length (L) of the DTG circumference section, fixed at the angles to a flat surface. Along the left and right edges, straight lines of 2.5-mm size are drawn ([Figure 7A](#f7){ref-type="fig"}) and these are needed for full restoration of the DTG integrity later. Thus, the circumference of DTG (after the later restoration of its integrity) will be L1, which equals to L minus 5 mm, and the diameter of DTG (D1) equals to the formula in [Figures 7B](#f7){ref-type="fig"} and [8A](#f8){ref-type="fig"}.

The length of DTG is divided in three equal parts on the back side ([Figure 7A](#f7){ref-type="fig"}). Based on a formula ([Figure 8B](#f8){ref-type="fig"}) for the calculation of the circumference around an equilateral triangle ([Figure 7B](#f7){ref-type="fig"}), we obtain the intercommissural distances ([Figures 7C](#f7){ref-type="fig"} and [8C](#f8){ref-type="fig"}) and the size of the Ozaki's template is selected, with the help of which we cut out three identical flaps from the treated autologous pericardium. At 5 mm from the bottom edge of DTG, a straight line is drawn (5 mm will be needed to fix the conduit to the aortic ring). A parallel straight line is also drawn at a distance from the first straight line, equal to the height (h) of the commissures ([Figures 7A](#f7){ref-type="fig"} and [7C](#f7){ref-type="fig"}), measured according to TEE. This line is then used for fixation of the neocusps to DTG ([Figure 7C](#f7){ref-type="fig"}). Further, a continuous suture line of prolene is used to fix the neocusps to the DTG ([Figure 9](#f9){ref-type="fig"}), which is wrapped around itself and restored (as a tube) with a continuous suture line of prolene ([Figures 7D](#f7){ref-type="fig"} and [10](#f10){ref-type="fig"}). The next step is the implantation of the resulting conduit with fixation of the proximal end to AVA with horizontal mattress stitches (Central Figure). Reimplantation of the coronary ostia is performed according to the standard technique. The procedure ends with a distal anastomosis of DTG with AA.

Fig. 9Continuous suture line of prolene is used to fix the neocusps to the Dacron tube graft (DTG).

Fig. 10The Dacron conduit is wrapped around itself and restored (as a tube) with a continuous suture line of prolene.

COMMENTS
========

Most researchers believe that AV prostheses lead to improved longevity, reduce complication rates, and improve quality of life^\[[@r9],[@r10]\]^. The preservation of residual obstruction of blood flow at the level of AV leads to a slower decrease in left ventricular hypertrophy and progression of heart failure^\[[@r9]-[@r12]\]^. The use of biological materials for AVNeo is nothing new. Back in the 1960s, the first operations, in which biological materials were used, were performed for AV-sparing procedure with cusp elongation and even completely replacement of the AV cusp^\[[@r3]\]^. The idea of AVNeo using autologous pericardium treated with glutaraldehyde was proposed in 1995 by Duran et al.^\[[@r13]\]^. Gasparyan^\[[@r14]\]^ proposed a formula to calculate the dimensions of the cusps for AVNeo^\[[@r14]\]^. The Ozaki method showed promising mid-term results. After following 416 patients for 73 months, the reoperation-free survival rate was 96.7%^\[[@r15]\]^. There is no doubt that autologous pericardial neovalves have very low thrombogenicity and provide hemodynamics similar to that in the native valve. Also important is the economic aspect, since we can avoid the use of costly prostheses. Further studies are warranted to determine the effectivity of the Russian conduit in the surgical treatment of AV and AA pathologies.
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